Akebia Therapeutics Inc. buy HC Wainwright
Start price
17.11.23
/
50%
€0.92
Target price
17.11.24
€4.60
Performance (%)
28.57%
Price
03.05.24
€1.28
Summary
This prediction is currently active. The prediction currently has a performance of 28.57%. This prediction currently runs until 17.11.24. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Akebia Therapeutics Inc. | 2.324% | 2.324% |
iShares Core DAX® | -0.922% | -1.993% |
iShares Nasdaq 100 | 0.371% | -0.868% |
iShares Nikkei 225® | 2.224% | -5.187% |
iShares S&P 500 | -0.026% | -0.918% |
Comments by HC_Wainwright for this prediction
In the thread Akebia Therapeutics Inc. diskutieren
Akebia Therapeutics, Inc. (NASDAQ: AKBA) had its price target raised by analysts at HC Wainwright from $3.75 to $5.00. They now have a "buy" rating on the stock.
Ratings data for AKBA provided by MarketBeat
Stopped prediction by HC_Wainwright for Akebia Therapeutics Inc.
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.82
28.03.24
28.03.24
€5.55
28.03.25
28.03.25
-29.99%
03.05.24
03.05.24
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.11
27.09.23
27.09.23
€3.55
27.09.24
27.09.24
14.84%
03.05.24
03.05.24
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.27
28.08.23
28.08.23
€3.47
28.08.24
28.08.24
0.55%
03.05.24
03.05.24